These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26811644)

  • 1. How to predict clinical relapse in inflammatory bowel disease patients.
    Liverani E; Scaioli E; Digby RJ; Bellanova M; Belluzzi A
    World J Gastroenterol; 2016 Jan; 22(3):1017-33. PubMed ID: 26811644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease monitoring in inflammatory bowel disease.
    Chang S; Malter L; Hudesman D
    World J Gastroenterol; 2015 Oct; 21(40):11246-59. PubMed ID: 26523100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, serological and genetic predictors of inflammatory bowel disease course.
    Beaugerie L; Sokol H
    World J Gastroenterol; 2012 Aug; 18(29):3806-13. PubMed ID: 22876031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal biomarkers in inflammatory bowel disease: how, when and why?
    Ministro P; Martins D
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):317-328. PubMed ID: 28276813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
    Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody markers in the diagnosis of inflammatory bowel disease.
    Mitsuyama K; Niwa M; Takedatsu H; Yamasaki H; Kuwaki K; Yoshioka S; Yamauchi R; Fukunaga S; Torimura T
    World J Gastroenterol; 2016 Jan; 22(3):1304-10. PubMed ID: 26811667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    García-Sánchez V; Iglesias-Flores E; González R; Gisbert JP; Gallardo-Valverde JM; González-Galilea A; Naranjo-Rodríguez A; de Dios-Vega JF; Muntané J; Gómez-Camacho F
    J Crohns Colitis; 2010 Jun; 4(2):144-52. PubMed ID: 21122498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy.
    Ferreiro-Iglesias R; Barreiro-de Acosta M; Otero Santiago M; Lorenzo Gonzalez A; Alonso de la Peña C; Benitez Estevez AJ; Dominguez-Muñoz JE
    J Clin Gastroenterol; 2016 Feb; 50(2):147-51. PubMed ID: 25811118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic scoring systems for inflammatory bowel disease: pros and cons.
    Tontini GE; Bisschops R; Neumann H
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):543-54. PubMed ID: 24650249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of environmental factors on the onset and course of inflammatory bowel disease.
    Dutta AK; Chacko A
    World J Gastroenterol; 2016 Jan; 22(3):1088-100. PubMed ID: 26811649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
    Costa F; Mumolo MG; Ceccarelli L; Bellini M; Romano MR; Sterpi C; Ricchiuti A; Marchi S; Bottai M
    Gut; 2005 Mar; 54(3):364-8. PubMed ID: 15710984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of the disease course in inflammatory bowel diseases].
    Kiss LS; Lakatos PL
    Orv Hetil; 2010 Feb; 151(8):293-301. PubMed ID: 20154000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.
    Lewis JD
    Gastroenterology; 2011 May; 140(6):1817-1826.e2. PubMed ID: 21530748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice.
    Levesque BG; Sandborn WJ; Ruel J; Feagan BG; Sands BE; Colombel JF
    Gastroenterology; 2015 Jan; 148(1):37-51.e1. PubMed ID: 25127678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we predict the high-risk patient?
    Benitez JM; Louis E
    Dig Dis; 2014; 32(4):328-36. PubMed ID: 24969276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.